Chronic fluvoxamine treatment changes 5-HT_<2A/2C>receptor-mediated behavior in olfactory bulbectomized mice
Chronic fluvoxamine treatment changes 5-HT_<2A/2C>receptor-mediated behavior in olfactory bulbectomized mice
复制标题
慢性氟伏沙明治疗改变嗅球切除小鼠的 5-HT_<2A/2C> 受体介导的行为
DOI:
10.1016/j.lfs.2012.11.005
复制
发表时间:
2012
期刊:
影响因子:
6.1
通讯作者:
Tadano T
中科院分区:
文献类型:
--
作者:
Oba A;Nakagawasai O;Onogi H;NemotoW;Yaoita F;Arai Y;Tan-No K;Tadano T
AIMSOlfactory bulbectomy (OBX) in rodents represents a valuable experimental model of depression. This study was designed to shed further light on the impact of putative serotonergic neuronal degeneration in OBX mice and to assess the effect of a widely used antidepressant on serotonergic related behavioral changes induced by OBX.MAIN METHODSAdult male ddY mice were subject to bilateral OBX or sham surgery. The serotonin (5-HT)2A/2Creceptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) enhanced a head-twitch response (HTR) in OBX mice. Effects of 5-HT2A, 5-HT2Cantagonists and fluvoxamine were observed in OBX mice following DOI administration.KEY FINDINGSThe HTR elicited by the administration of DOI (0.5mg/kg and 1mg/kg, i.p.) was increased about twofold in OBX mice when compared with controls on the 14th day after the surgery. The injection of ketanserin (0.025mg/kg, i.p.), a 5-HT2Areceptor antagonist, inhibited the enhancement of the DOI-induced HTR after OBX. Likewise, the administration of SB 242084 (1mg/kg, s.c.), a 5-HT2Creceptor antagonist, also inhibited the DOI-induced HTR in OBX mice. Chronic but not acute treatment with the antidepressant fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), suppressed the enhancement of DOI-induced HTR after OBX.SIGNIFICANCEThese findings indicate that OBX, and the subsequent degeneration of neurons projecting from the olfactory bulb, caused a supersensitivity of 5-HT2A/2Creceptors which may be involved in symptoms of depression.